Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents
US8642604B2 · kind B2 · utility
63Cited by
140References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2009 |
| Grant date | Feb 4, 2014 |
| Priority date | — |
| Expiry date | May 29, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tyrosine kinase, PI3 kinase and mTOR, or PI33 kinase, mTOR and tyrosine kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.